TOP STORY Long-Term Human Pluripotent Stem Cell Self-Renewal on Synthetic Polymer Surfaces Researchers identified several polymers that can support self-renewal of human pluripotent stem cells (hPSCs). While most of these polymers provide support for only a short period of time, the researchers identified a synthetic polymer poly(methyl vinyl ether-alt-maleic anhydride) that supported the long-term attachment, proliferation and self-renewal of HUES1, HUES9, and iPSCs. [Biomaterials]
|
|
SCIENCE NEWS How Physical Environment Influences Stem Cell Development Research has revealed how physical qualities — and not only chemical ones — may have an influence in determining how adult stem cells from the bone marrow develop into differentiated ones. [Press release from ScienceDaily discussing online prepublication in Nature Physics] | | | Use AggreWell® for Reproducible, Uniform Embryoid Bodies by STEMCELL Technologies |
| | | | |
|
|
INDUSTRY NEWS Pfizer to Acquire FoldRx Pharmaceuticals Pfizer Inc. and FoldRx Pharmaceuticals, Inc. announced that they have entered into an agreement under which Pfizer will acquire FoldRx. [FoldRx Pharmaceuticals, Inc. Press Release] Forbion Capital Partners Raises EUR190 Million for New Investments Forbion Capital Partners, a leading investment firm dedicated to the life science sector, announced the final closings of both FCF I Co-Invest Fund and of FCF II, raising a total of more than EUR190 million ($240 million). [Forbion Capital Partners Press Release] Health Science Center Lands $11.6 Million to Study Cardiac Proteins A blood test to diagnose which heart attack survivors will suffer heart failure is the goal of a new five-year, $11.6 million contract to the University of Texas Health Science Center San Antonio from the National Heart, Lung and Blood Institute. [University of Texas Health Science Center San Antonio Press Release] Actavis Plans to Enter into Biosimilars Actavis Group announced that it plans to enter into the field of biosimilars. [Actavis Group Press Release] Halozyme Therapeutics Announces Public Offering of Common Stock Halozyme Therapeutics, Inc. announced that it is offering to sell 8.3 million shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. [Halozyme Therapeutics, Inc. Press Release] Cell Therapy Foundation Calls for Additional Research, Extensive Clinical Trials Some of the most promising medical research conducted to treat diseases of the brain, heart, and circulatory system is moving too slowly to help millions of patients, according to the Cell Therapy Foundation, which advocates the use of adult stem cells to dramatically impact and improve the condition of patients who suffer from a variety of conditions. [PR Newswire]
|
|
POLICY NEWS Judge Upholds Stem Cell Funding Ban A Washington, D.C., judge said that his ruling, halting all federal funding for human embryonic stem cell research, will stand while the case moves forward. Chief Judge Royce Lamberth, responding to a request from the Department of Justice that he stay his preliminary injunction, released a 3-page order denying the request. [United States District Court for the District of Columbia] FDA Launches New Organizational Performance Management System The U.S. Food and Drug Administration (FDA) launched an innovative performance management system designed to advance the President’s commitment to transparency, public participation, and collaboration in the work of government. [Food and Drug Administration, United States] Medical School Leaders Express Support for Stem Cell Research in New AAMC Ad [Association of American Medical Colleges, United States] Center for Scientific Review; Notice of Closed Meeting (FR Doc. 2010-22096) [National Institutes of Health, United States] Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-22128) [National Institutes of Health, United States] Center for Scientific Review; Amended Notice of Meeting (FR Doc. C1-2010-22119) [National Institutes of Health, United States] Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meeting (FR Doc. 2010-22107) [National Institutes of Health, United States] National Cancer Institute; Notice of Closed Meetings (FR Doc. 2010-22093) [National Institutes of Health, United States] National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting (FR Doc. 2010-22327) [National Institutes of Health, United States]
|
|
EVENTS (Listed by Date) 23rd European Conference on Biomaterials September 11-15, 2010 Tampere, Finland Hydra VI: The European Summer School on Stem Cells & Regenerative Medicine September 11-17, 2010 Hydra, Greece Stem Cells USA & Regenerative Medicine Congress 2010 September 13-15, 2010 Philadelphia, United States Tissue Engineering & Regenerative Medicine International Society (TERMIS) – Asia Pacific 2010 September 15-17, 2010 Sydney, Australia 15th Congress of the European Society of Surgical Oncology (ESSO) September 15-17, 2010 Bordeaux, France 9th Annual Human Proteome Organization (HUPO) World Congress September 19-23, 2010 Sydney, Australia NEW Third Annual Maryland Stem Cell Research Symposium September 22, 2010 Gaithersburg, United States Symposium on Advanced Wound Care September 23-25, 2010 Anaheim, United States 4th International Conference on Biofabrication October 4-6, 2010 Philadelphia, United States bone-tec 2010 – International Bone-Tissue-Engineering Congress October 7-10, 2010 Hannover, Germany 35th European Society for Medical Oncology (ESMO) Congress October 8-12, 2010 Milan, Italy BioStar 2010 – 4th Congress on Regenerative Biology and Medicine October 13-15, 2010 Stuttgart, Germany American Society for Matrix Biology (ASMB) 2010 Biennial Meeting October 24-27, 2010 Charleston, United States Select Biosciences 2nd Annual Lab-on-a-Chip World Congress October 28-29, 2010 San Diego, United States Fraunhofer Life Science Symposium 2010 October 29-30, 2010 Leipzig, Germany BioMalaysia 2010 Conference and Exhibition November 2-4, 2010 Kuala Lumpur, Malaysia 6th National Cancer Research Institute (NCRI) Conference November 7-10, 2010 Liverpool, United Kingdom Select Biosciences 2nd International Forum on Stem Cells (2010 IFSC) November 12-13, 2010 Tianjin, China Medica 2010 November 17-20, 2010 Dusseldorf, Germany Translational Excellence in Regenerative Medicine – Biophysical Stimuli and Mass Transport for Tissue Development November 18-19, 2010 Lattrop, The Netherlands First Berlin-Brandenburg School for Regenerative Therapies (BSRT) PhD Symposium December 1-3, 2010 Berlin, Germany Tissue Engineering & Regenerative Medicine International Society (TERMIS) – North America 2010 Annual Conference December 5-8, 2010 Orlando, United States 50th Anniversary American Society for Cell Biology Annual Meeting December 11-15, 2010 Philadelphia, United States Epithelial Plasticity and Epithelial to Mesenchymal Transition January 21-26, 2011 Vancouver, Canada Select Biosciences 5th Annual Stem Cells World Congress January 24-25, 2011 San Diego, United States Phacilitate 7th Annual Cell & Gene Therapy Forum 2011 January 24-26, 2011 Washington, DC, United States Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES Cell Therapy Technologist (Opexa Therapeutics) Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News. Visit here to post your career opportunities.
Have we missed an important article or publication in Extracellular Matrix News? Click here to submit! |
|
|
|